Barinthus Biotherapeutics BRNS
BRNS
$0.74 +0.00 (+0.00%)
At close: Sep 18, 2026 · 4:00 PM EDT

Barinthus Biotherapeutics (BRNS) EV to EBITDA (2022)

Updated

Barinthus Biotherapeutics' EV to EBITDA came in at -297.25 for Q4 2022.

Analysis

Barinthus Biotherapeutics (BRNS) EV to EBITDA (2022) Analysis & Trends

For FY2022, Barinthus Biotherapeutics' EV to EBITDA was -374.20.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Barinthus Biotherapeutics 30.23 Mn 30.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -297.25
Sep 30, 2022 -10.15
API Access

Barinthus Biotherapeutics EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=BRNS&period=max&api_key=YOUR_API_KEY